Tirzepatide 99.9% Purity — Allen Biotechnology Co AbcCertificate of Analysis · Independent third-party lab result

Extracted via OCR. Names, emails, phone numbers, and street addresses are auto-redacted before display.

FINNRICK Finnrick Testing Certificate Test Certificate ID: sbm9sf7 Verify at https://finnrick.com/verify Page 1 of 2
BT Labs
Report #:
IF-824-QSA-TR006-2026-115-92
Page 1 of 2
Title:
Certificate of Analysis (CoA)
Date:
3/4/2026
Date Tested:
3/1/2026
Customer:
Finnrick
Testing material:
Tirzepatide
Lot Number:
SBM9SF7
BT Sample ID:
005000039009629
Labeled Peptide
Content/Potency:
30 mg
Storage:
R.T.
Visual Description:
small clear vial: white sample, white label, silver crimp, orange plastic cap.
Labeled as:
Tirzepatide
Manufacturer:
n/a
Testing Purpose:
FTIR and HPLC analysis for the identification, purity, potency and composition of a
peptide product. It does not provide information on particulate matter, microbial
contamination or presence of endotoxins.
Test
Method
Specification
Result
General [NAME_REDACTED]
USP
<630>
white powder
white powder
Mass
USP
<41>
As recorded
80.9 mg
FTIR Identification
and Composition
Analysis
USP
<197A>
Sample spectrum should confirm
the content of peptide via
characteristic bands
FTIR sample spectrum
confirms the presence of
Tirzepatide with addition of
excipient(s)/fillers.
HPLC Purity of
Peptide Assay
USP
<621>
Specifications: ≥ 98 %
99.9 %
[NAME_REDACTED]
USP
<621>
Specifications: 90 - 110% of 30
mg
35.4 mg (118 %)
Peptide-to-Excipients
Ratio
USP
<1151>
Recommended ratios of (1:2) to
(1:10) for (peptide: excipients)
35.4 : 45.5 mg (1:1.3)
The results of the CoA relate only to the item(s) tested and applied to the sample as received.
[NAME_REDACTED],
AS
Digitally signed by [NAME_REDACTED],
AS
DN: CN=BTLabs, OU=BioTools Inc.,
E=[EMAIL_REDACTED]
Reason: I am the author of
this document
Location:
Date: 2026.03.05
16:30:17
-05'00'
Foxit PDF Reader Version:
2025.1.0
[NAME_REDACTED],
AS
Digitally signed by [NAME_REDACTED], AS'
DN: CN=[NAME_REDACTED], AS',
E=[EMAIL_REDACTED]
Reason: I am the author of
this document
Location:
Date: 2026.03.05
16:30:17
-05'00'
Foxit PDF Reader Version:
2025.1.0
[NAME_REDACTED], AS
Scientist-I
BTLabs
[NAME_REDACTED], AS
Scientist-I
BTLabs
[ADDRESS_REDACTED] | Suite 220 | West Palm Beach, FL 33407
Phone: [PHONE_REDACTED]
E-mail: [EMAIL_REDACTED] | Website: https://btlabtesting.com
Finnrick Testing Certificate © 2026 Finnrick Analytics LLC and its suppliers, all rights reserved. Unauthorized distribution and modification prohibited.
IF-824-QSA-TR006-2026-115-92
Rev 1.0 January 2025